These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 7758913)
21. FDA drug approvals: no worse is simply not good enough. Nat Biotechnol; 1996 Apr; 14(4):403. PubMed ID: 9630904 [No Abstract] [Full Text] [Related]
22. FDA new drug approvals in 2008. Wynn RL Gen Dent; 2009; 57(4):300-4. PubMed ID: 19903606 [No Abstract] [Full Text] [Related]
23. FDA notifications. New guidance assists HIV drug development. Changes affect approvals for antiretroviral drugs. AIDS Alert; 2003 Jan; 18(1):10-1. PubMed ID: 12541998 [TBL] [Abstract][Full Text] [Related]
24. The history and contemporary challenges of the US Food and Drug Administration. Borchers AT; Hagie F; Keen CL; Gershwin ME Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043 [TBL] [Abstract][Full Text] [Related]
25. Significant FDA approvals in 1999. McGinnis TJ Am Fam Physician; 2000 Apr; 61(8):2531-3. PubMed ID: 10794586 [No Abstract] [Full Text] [Related]
26. Defending submission-year analyses of new drug approvals. Carpenter DP Health Aff (Millwood); 2003; Suppl Web Exclusives():W4-S3-W4-S5. PubMed ID: 15526399 [TBL] [Abstract][Full Text] [Related]
27. 2007 FDA drug approvals: a year of flux. Hughes B Nat Rev Drug Discov; 2008 Feb; 7(2):107-9. PubMed ID: 18246607 [No Abstract] [Full Text] [Related]
28. FDA makes final approvals. AIDS Patient Care STDS; 2006 May; 20(5):381. PubMed ID: 16758553 [No Abstract] [Full Text] [Related]
29. FDA approvals of old drugs put new pressure on payers. Silverman E Manag Care; 2011 May; 20(5):30-1. PubMed ID: 21667624 [No Abstract] [Full Text] [Related]
30. 2012 FDA drug approvals. Mullard A Nat Rev Drug Discov; 2013 Feb; 12(2):87-90. PubMed ID: 23370234 [No Abstract] [Full Text] [Related]
31. FDA hastening withdrawal of fluoroquinolone approvals for poultry. J Am Vet Med Assoc; 2000 Nov; 217(10):1447, 1452. PubMed ID: 11128524 [No Abstract] [Full Text] [Related]
32. FDA: friend or foe? Lewis TS Med Device Technol; 1996 Nov; 7(9):24-30. PubMed ID: 10163675 [TBL] [Abstract][Full Text] [Related]
33. New drug approvals in 1997. Wynn RL Gen Dent; 1998; 46(3):230-2, 234, 236. PubMed ID: 9693535 [No Abstract] [Full Text] [Related]
34. Therapeutic recombinant proteins: trends in US approvals 1982 to 2002. Reichert JM; Paquette C Curr Opin Mol Ther; 2003 Apr; 5(2):139-47. PubMed ID: 12772503 [TBL] [Abstract][Full Text] [Related]
35. Keeping abreast of new drug approvals and labeling changes. Rheinstein PH; Tsai VW Am Fam Physician; 1998 Sep; 58(4):995-8. PubMed ID: 9767730 [No Abstract] [Full Text] [Related]
36. Will FDA relinquish the "gold standard" for new drug approval? Redefining "substantial evidence" in the FDA Modernization Act of 1997. Kulynych J Food Drug Law J; 1999; 54(1):127-49. PubMed ID: 11758555 [No Abstract] [Full Text] [Related]
37. FDA evaluates accelerated approval process. Food and Drug Administration. Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343 [TBL] [Abstract][Full Text] [Related]
38. The year in review. A panoply of product approvals. Nordenberg T FDA Consum; 2000; 34(3):10-2. PubMed ID: 11521248 [No Abstract] [Full Text] [Related]
39. FDA shortened drug approval time in 1995. Public Health Rep; 1996; 111(4):290. PubMed ID: 8711090 [No Abstract] [Full Text] [Related]
40. Whatever happened to user fees and the FDA's promise to expedite new drug approvals? Gatty B Hosp Formul; 1993 Jul; 28(7):656, 655. PubMed ID: 10127048 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]